Don't miss important news
Sign up for a digest of the most important news every month.
Latest News
New trial data shows volixibat significantly reduces severe itch for people with PSC.
Applications now open for our 2027 TCS London Marathon charity places!
Discover how PSC Support is accelerating research, from novel diagnostics to gut health, this month.
Register for our upcoming Ask the Expert live PSC Q&A with Dr Joshi, taking place on 2nd May at 1pm (UK).
PSC Support announces new research funding, pushing our total Mission 2030 investment to £852,588.
Early-phase study shows brodalumab is safe and well-tolerated in people with PSC.
To mark Rare Disease Day, Jenny stood up in front of her local church to share her personal experience of living with PSC. Her daughter Sophie was on hand selling and making bespoke loom band bracelets and key chains after being inspired by Liyana.
A summary of recent clinical trial results, new research funding, and a historic NICE evaluation.
Safety results for the Phase 2 ritivixibat study (A3907) for PSC have been released.
Exploring the role of GLP-1 medications and what the latest research means for our community.